Masseter Thickness, Bruxism, and Oral Behaviors in Chronic Neck Pain

ConditionNeck Pain
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorBeylikduzu State Hospital

About this trial

A total of 30 patients aged 18-65 years who present with chronic non-specific neck pain and 30 healthy volunteers will be included in the study. Patients with symptoms persisting for at least 3 months will be eligible for inclusion. Necessary information will be provided to all participants, and informed consent will be obtained.

To assess pain severity before treatment, participants will be asked to rate their complaints using the Visual Analog Scale (VAS), a linear scale for pain assessment. The Neck Disability Index will be used to determine the level of disability.

The Jaw Functional Limitation Scale-20 (JFLS-20), Patient Health Questionnaire-9 (PHQ-9), Patient Health Questionnaire-15: Physical Symptoms, Generalized Anxiety Disorder-7 (GAD-7), and the Oral Behaviors Checklist-included in Axis 2 of the DC/TMD form developed for evaluating temporomandibular joint dysfunction-will be used to assess patients' psychosocial characteristics and parafunctional habits.

Additionally, masseter muscle thickness will be evaluated using ultrasonographic measurement.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed with chronic non-specific neck pain

Aged between 18-65 years

Symptoms persisting for at least 3 months

Disqualifiers

Pregnancy

Presence of psychiatric or neurological diseases

Use of psychiatric medications

Cognitive impairment

Trial population

The study population will consist of 30 patients diagnosed with chronic non-specific neck pain and 30 healthy volunteers, aged between 18 and 65 years.

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

60 Participants
are grouped into 2 trial groups
Group A: Neck pain group
Group B: Healthy controls

Trial outcomes

Primary outcomes

1

Masseter Muscle Thickness

Measured using ultrasonography, with values interpreted in relation to clinical findings. No fixed score range; thickness is recorded in millimeters.

Time frame
0 day

Secondary outcomes

1

Visual Analog Scale (VAS)

A linear scale used to assess pain severity, where higher scores indicate more severe pain. Score range: 0-10.

Time frame
0 day
2

Neck Disability Index

A questionnaire used to evaluate the level of disability related to neck pain, with higher scores reflecting greater disability. Score range: 0-100.

Time frame
0 day
3

Patient Health Questionnaire-9 (PHQ-9)

A scale measuring the severity of physical symptoms, where higher scores represent greater somatic symptom burden. Score range: 0-30.

Time frame
0 day
4

Generalized Anxiety Disorder-7 (GAD-7)

A scale used to assess anxiety levels, with higher scores indicating more severe anxiety symptoms. Score range: 0-21.

Time frame
0 day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.